Goswami B B, Manna P K, Basu S K
Division of Pharmaceutics, Regional Pharmacy Institute, Tripura, India.
Arzneimittelforschung. 1995 Jul;45(7):813-4.
Erythromycin nalidixate was prepared by combining nalidixic acid with erythromycin base. Thin-layer chromatographic studies and infrared absorption spectrum confirmed homogeneity of the new salt. The salt is very soluble in nonpolar solvent and freely soluble in polar solvent. The salt is quite stable at room temperature (30 +/- 1 degrees C). The antimicrobially active dose of the salt was found to be 820 micrograms/mg. Serum protein binding amounted to 85% and was reversible. LD50 in mice was found to be 371.5 mg/kg when the intraperitoneal route was used.
萘啶酸红霉素是通过将萘啶酸与红霉素碱结合制备而成的。薄层色谱研究和红外吸收光谱证实了这种新盐的同质性。该盐在非极性溶剂中极易溶解,在极性溶剂中易溶。该盐在室温(30±1℃)下相当稳定。发现该盐的抗菌活性剂量为820微克/毫克。血清蛋白结合率达85%,且是可逆的。当采用腹腔注射途径时,小鼠的半数致死量为371.5毫克/千克。